Stocktoria
GeoVax Labs, Inc. GOVX
GeoVax Labs, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $4.0M | $0 | $81,526 | $385,501 | $1.8M | $1.2M | $963,203 | $1.1M | — |
| R&D expense | $18.1M | $23.7M | $20.7M | $9.1M | $15.6M | $2.4M | $1.9M | $1.9M | $2.0M | — |
| Operating income | -$21.6M | -$25.1M | -$26.7M | -$14.0M | -$18.7M | -$2.8M | -$2.4M | -$2.6M | -$2.2M | — |
| Interest expense | — | — | — | $0 | $1,286 | $143,524 | $4,495 | $2,590 | — | — |
| Income tax | $0 | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$21.5M | -$25.0M | -$26.0M | -$14.0M | -$18.6M | -$3.0M | -$2.4M | -$2.6M | -$2.2M | — |
| Operating cash flow | -$21.5M | -$24.7M | -$25.2M | -$19.0M | -$11.2M | -$2.8M | -$1.4M | -$1.5M | -$1.7M | — |
| Free cash flow | -$21.5M | -$24.7M | -$25.2M | -$19.2M | -$11.2M | -$2.9M | -$1.4M | — | -$1.7M | — |
| Cash & equivalents | $3.1M | $5.5M | $6.5M | $27.6M | $11.4M | $9.9M | $283,341 | $259,701 | $312,727 | $343,826 |
| Total assets | $6.3M | $8.2M | $9.3M | $31.3M | $11.8M | $10.4M | $468,880 | $642,064 | $490,235 | $495,635 |
| Total liabilities | $2.5M | $3.1M | — | $4.7M | $7.4M | $825,047 | $2.0M | $1.7M | $811,292 | — |
| Shareholders' equity | $3.8M | $5.0M | $5.8M | $26.6M | $4.4M | $9.6M | -$1.6M | -$1.0M | -$321,057 | -$235,907 |
Growth · year-over-year · Revenue CAGR 11.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -37.1% | — | -100.0% | -78.9% | -78.9% | +55.1% | +22.1% | -10.4% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.